Announced Thu, 25 Jun · 15:16 IST
Trading window closed from July 1 ahead of Q1 results
Compliance View source PDF
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹1528.10
prior close
₹1555.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0——+0.7+3.0+1.4+2.3+5.8+3.6+0.5+1.5——
Up moveDown movePending
AI summary
Aurobindo Pharma has closed its trading window from July 1, 2026 until 48 hours after the declaration of Q1 unaudited financial results for the quarter ending June 30, 2026. The restriction applies to all designated persons including promoters, directors, KMPs, employees, connected persons and their immediate relatives. This is done as per the company internal code of conduct to regulate insider trading. Board meeting date for the results announcement will be communicated later.
Likely market impact
Routine compliance filing signalling upcoming Q1 results. No direct impact on retail shareholders or stock price.